NHS Organisations to Access IMS MAXIMS Cloud-Based Services on G Cloud 9 Framework

IMS MAXIMSAward-winning electronic patient record (EPR) provider IMS MAXIMS has announced the availability of its cloud services on the latest iteration of the UK Government's G Cloud Framework. NHS organisations looking for a cost-effective and efficient way to purchase cloud-based solutions that enable their paperless 2020 ambitions, can use G Cloud 9 to access a range of IMS MAXIMS professional implementation services. To support the successful deployment of their EPR, openMAXIMS, the company is offering configuration, benefits realisation, data migration, project management, software testing and staff training on the Framework. Implemented together, this approach to healthcare transformation can enable Trusts to deploy an EPR system in 6 to 12 months, rather than the 18 to 24 months typically needed.

IMS MAXIMS appointment to G Cloud 9 is one of several achievements in recent months. Last month they were awarded a place on the NHS Clinical and Digital Information Systems Framework and earlier in the year, their specialist services were re-listed on the recently updated Government Framework for Digital Outcomes and Specialists (DOS). The company has been involved in the G Cloud Framework since it was established in 2012.

"NHS organisations looking to advance their digital journey and meet Government’s paperless aspirations can now access our support services across a variety of Government Frameworks," said CEO of IMS MAXIMS, Shane Tickell.

He added, "G Cloud 9 is the latest Framework that gives NHS customers an alternative, more effective route to buying digital services, helping them avoid lengthy OJEU procurement processes that can often constrain buying decisions. At a time when the health system so desperately needs to reap the benefits of technology, we think this Framework is vitally important to the NHS and UK plc."

NHS organisations wanting to deploy IMS MAXIMS full suite of patient information and clinical software solutions - which is available on an open source basis - can access it without a license fee via software development platform, GitHub.

Notable use of openMAXIMS in the NHS has been widely publicised. The company's partnership with Taunton and Somerset NHS Foundation Trust, helped the organisation to become a Global Digital Exemplar last year, recognised by Government for its innovative digital offering. Similar transformation programmes are underway elsewhere in the country, including Blackpool Teaching Hospital NHS Foundation Trust, Wye Valley NHS Trust and Ramsay Healthcare.

About IMS MAXIMS
IMS MAXIMS is an award winning clinical technology specialist committed to improving the coordination of patient care in healthcare environments. Its expert team works in partnership with healthcare organisations to identify and deliver tailored, sustainable information sharing technology solutions supporting the provision of safer and more efficient care for current and future generations.

The organisation's 30-year history of collaborating with clinicians has resulted in the development of proven, flexible, user-friendly, safe and interoperable open source electronic patient record software. With an ambition to meet today’s healthcare challenges, IMS MAXIMS makes its software available without a licence fee and offers flexible options to support healthcare providers with implementation and maintenance.

Its open technology has increased collaboration in the development of the software which has resulted in better clinical engagement and empowerment across hospital wards and departments. Deployment times are fast, meaning clinicians and patients can benefit from efficiency and safety improvements in rapid time.

In 2017 IMS MAXIMS was named Best Performing Company for Government and Healthcare Systems and Overall Winner at the Megabuyte Emerging Stars Awards.

Most Popular Now

Zebra Announces Regulatory Approval of i…

Zebra Medical Vision, the leading machine learning imaging analytics company, announces that the company has been granted the CE approval and subsequent release of its Deep Learning Analytics Engine in...

Mind-Controlled Device Helps Stroke Pati…

Stroke patients who learned to use their minds to open and close a device fitted over their paralyzed hands gained some control over their hands, according to a new study...

Philips and Illumina Team Up with Navica…

Royal Philips (NYSE: PHG, AEX: PHIA) and Navican, an Intermountain Healthcare company, today signed an agreement to deploy a precision health informatics solution that will allow hospitals and health systems...

NHS Organisations to Access IMS MAXIMS C…

Award-winning electronic patient record (EPR) provider IMS MAXIMS has announced the availability of its cloud services on the latest iteration of the UK Government's G Cloud Framework. NHS organisations looking...

Boehringer Ingelheim Builds Digital Lab …

With the founding of BI X as independent subsidiary Boehringer Ingelheim will focus on breakthrough innovative digital solutions in healthcare from idea to pilot. The start-up will work closely together...

Artificial Intelligence to Assist in the…

The University of Tampere and TAYS (Tampere University Hospital) Heart Hospital use artificial intelligence (A.I.) technologies developed by VTT Technical Research Centre of Finland in the home care of heart...

Anyone can Become More Curious. Is that …

Merck, a leading science and technology company, today announced the start of an experiment entitled "Anyone can become more curious". Driven by the company’s curiosity initiative, which measured and described...

EC Open Call FETOPEN-01-2016-2017: FET-O…

The successful exploration of new foundations for radically new future technologies requires supporting a large set of early stage, high risk visionary science and technology projects to investigate new ideas...

Home Monitoring of Blood Sugar Did Not I…

Self-monitoring of blood glucose levels in patients with type 2 diabetes who are not treated with insulin did not improve glycemic control or health-related quality of life after one year...

Call for Applications: 2017 Lyfebulb-Nov…

For the second year in a row, Lyfebulb and Novo Nordisk will support international patient entrepreneurs who develop innovative ideas and concepts aimed to positively empower and impact the lives...

New Cellular Imaging Paves Way for Cance…

Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease...

UK PACS Win for Carestream Announced

West Hertfordshire Hospitals NHS Trust (West Herts) located in the South East of the UK and Carestream have signed and exchanged contracts to replace the Trust's existing PACS with a...